Tau protein hyperphosphorylation was the first pathological post-translational modification of tau protein described in Alzheimer’s disease (AD), highlighting the role of PKs in neurodegeneration. The gene discussed is MAPT; the disease is early-onset autosomal dominant Alzheimer disease.